Where does Miltenyi Biotec B.V. & Co. KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Miltenyi Biotec B.V. & Co. KG ranks #7,589 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Miltenyi Biotec B.V. & Co. KG hold?

Miltenyi Biotec B.V. & Co. KG holds 43 US utility patents granted between 2020 and 2025, spanning 19 technology areas.

What is Miltenyi Biotec B.V. & Co. KG's Innovation Score?

Miltenyi Biotec B.V. & Co. KG has an Innovation Score of 56.4 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Miltenyi Biotec B.V. & Co. KG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Miltenyi Biotec B.V. & Co. KG.

What does claim depth mean for Miltenyi Biotec B.V. & Co. KG's patents?

Miltenyi Biotec B.V. & Co. KG's patents average 13.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Miltenyi Biotec B.V. & Co. KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Miltenyi Biotec B.V. & Co. KG

Q: What technology areas does Miltenyi Biotec B.V. & Co. KG focus on?

Miltenyi Biotec B.V. & Co. KG's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 23 patents, ranking #461 of 4,144 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

USPTO PatentsView assignee record - 43 granted patents across 19 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Miltenyi ranks #7,589 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 19 technology areas.

#7,589
of 49,997 US assignees by volume: Top 6%
by Innovation Score (56.4/100): 13.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7589 · Foreign Corporation #7,589 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 43 grants
UPPER-Q #7,589/49,997
PHOTO-FINISH Kito
CPC-FOCUS C12N · 19 areas
INNOV-PAR 56.4/100
CLAIMS-RICH 13.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Kito Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Miltenyi’s 56.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (23%) Velocity 20.0 pts (35%) Breadth 15.4 pts (27%) Claim depth 7.9 pts (14%)

Qualcomm Incorporated · highest

85
Alnylam Pharmaceutic… · near

56
Hollister Incorporated · near

56
Miltenyi Biotec B V… · this assignee

56
Rovi Product · near

56
Vortex Pipe Systems · near

56
3D Lighting… · lowest

7

What this shows Miltenyi's Innovation Score is 56.4/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Miltenyi?

Each dot is one of Miltenyi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Miltenyi’s own 13.2 claims/patent is ABOVE the 8.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Miltenyi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Miltenyi's grants concentrate

Miltenyi Biotec B.V. & Co. KG is a focused PatentsView assignee: 19 CPC subclasses with 53.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (12 grants) versus a trough of 3 in 2021. By volume, Miltenyi sits between Kito Corporation and Medtronic Ireland Manufacturing Unlimited Company.

Miltenyi's three-year grant acceleration

Miltenyi Biotec B.V. & Co. KG shows 25 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Kito

43
Leer Group

43
Lovevery

43
Meps Real-time

43
Miyakoshi Printin…

43
Mobotix

43
Medical Research…

43
Medtronic Ireland…

43
Miltenyi Biotec B… ◀

43

What this shows Miltenyi holds 43 patents at rank #7,587, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Miltenyi

By rank, the assignees closest to #7,587 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Miltenyi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Miltenyi, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Miltenyi ranks #461 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Rovi Product Corporation 56 Vortex Pipe Systems LLC 56 Hollister Incorporated 56 Alnylam Pharmaceuticals, Inc. 56

Miltenyi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Miltenyi Biotec B.V. & Co. KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	4	9.3%
2021	3	7.0%
2022	7	16.3%
2023	6	14.0%
2024	12	27.9%
2025partial year	11	25.6%

Which technologies does Miltenyi Biotec B.V. & Co. KG patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 23

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

C07K - Peptides 12

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 7

B04B - Centrifuges 6

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 6

B01D - Separation 6

G02B - Optical Elements, Systems OR Apparatus 4

H04N - Pictorial Communication, e.g. Television 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Miltenyi Biotec B.V. & Co. KG's patent record in context - here's where to go next.

Miltenyi Biotec B.V. & Co. KG's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 53.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #7,589 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Miltenyi Biotec B.V. & Co. KG against Kito Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 56.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.